Business

WeightWatchers Enhances Enterprise Offering with Full-Spectrum Access to Weight Health

Complete weight health platform with individualized pathways inclusive of both behavioral and clinical interventions and science-proven tools for employers

articleWw International, Inc.October 6, 20235/company/ww-international-inc/news/weightwatchers-enhances-enterprise-offering-with-full-spectrum-access-to-weight-health
WeightWatchers Enhances Enterprise Offering with Full-Spectrum Access to Weight Health

About this update from Ww International, Inc.

[{"type":"text","content":"Complete weight health platform with individualized pathways inclusive of both behavioral and clinical interventions and science-proven tools for employers and health plans\nNEW YORK, Oct. 06, 2023 (GLOBE NEWSWIRE) -- WeightWatchers (NASDAQ: WW), (“WeightWatchers,” “WW,” or the “Company”) announced today that WeightWatchers for Business has fully integrated WW’s science-proven behavioral program with its virtual obesity clinic and medication management. The Company now offers a full spectrum weight health platform designed for employers and health plans, that delivers individualized member pathways based on true clinical need. As prevalence of chronic diseases increases, organizations are challenged with higher costs, with experts predicting a 2-10% increase in insurance premiums in 20241. Among the many contributing factors are the increased utilization and cost of GLP-1 medications indicated for weight loss and diabetes. To help organizations navigate this new landscape, WeightWatchers for Business is building on its 30+ years of science-backed expertise in the employer-sponsored healthcare space with a complete cost management and utilization strategy that includes preventing progression and facilitating remission of weight-related conditions, as well as managing weight before, during, and after pharmacotherapy. WeightWatchers for Business utilizes evidence-based clinical pathways and step therapy with proprietary de-escalation protocols designed to drive clinically significant outcomes while controlling cost. “Health plans, PBMs, and their clients are grappling with unprecedented demand for this new class of chronic weight management medications and the associated costs,” stated Kevin O'Brien, Senior Vice President of Commercial Growth and Customer Operations for WeightWatchers. “Organizations are likely to face higher expenditures in this category, extending beyond the treatment of obesity. Our aim is to guide our partners to manage costs at scale, while providing long-term weight health for their people.” The complete weight health platform includes: WW’s science-proven behavior change program for sustained outcomes, including a program tailored for diabetes, as well as, later this year, a program tailored for those on GLP-1 medicationsRobust virtual and in-real-life communityCoach support at scaleIntegrated health insight...

More updates from Ww International, Inc.